Results 91 to 100 of about 6,634,184 (388)

Efficacy of BioFire FilmArray Gastrointestinal Panel (FGP) to Reduce Hospital Costs Associated With Contact Isolation: A Pragmatic Randomized Controlled Trial [PDF]

, 2021
Giulio DiDiodato, Ashley Allan, Nellie Bradbury, Julia Brown, Kelly Cruise, Christopher Jedrzejko, Valerie MacDonald, Jessica Pigeon, Amanda Sturgeon, Daniel Yellenik   +9 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

How Much Benefit Can Patients Acquire from Enhanced Recovery After Surgery Protocols with Percutaneous Endoscopic Lumbar Interbody Fusion?

International Journal of General Medicine, 2021
Junfeng Gong,* Liwen Luo,* Huan Liu, Changqing Li, Yu Tang, Yue Zhou Department of Orthopedics, The Second Affiliated Xinqiao Hospital of Army Military Medical University, Chongqing, People’s Republic of China*These authors contributed ...
Gong J, Luo L, Liu H, Li C, Tang Y, Zhou Y   +5 more
doaj  

Do waiting times reduce hospital costs? [PDF]

Using a sample of 137 hospitals over the period 1998-2002 in the English National Health Service, we estimate the elasticity of hospital costs with respect to waiting times.
Anderson Stanciole, Luigi Siciliani, Rowena Jacobs   +2 more
core  

Aiming Higher: Results From a State Scorecard on Health System Performance [PDF]

, 2007
Assesses state variation across key dimensions of health system performance -- access, quality, avoidable hospital use and costs, equity, and healthy lives -- and assigns overall state rankings as well as ranks on each ...
Cathy Schoen, Dina Belloff, Douglas McCarthy, Joel C. Cantor, Sabrina K. H. How   +4 more
core  

Liquid Hydroxyurea (Xromi) for Children With Sickle Cell Anemia: A New Solution Compounding Existing Problems

Pediatric Blood &Cancer, EarlyView.
Alexandra Power‐Hays, Charles T. Quinn
wiley   +1 more source

Cis‐regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation

Molecular Oncology, EarlyView.
The noncoding region of the genome plays a key role in regulating gene expression, and mutations within these regions are capable of altering it. Researchers have identified multiple functional noncoding mutations associated with increased cancer risk in the genome of breast cancer patients.
Arnau Cuy Saqués, Aracele Martinez‐Mendez, John Crown, Alex Eustace   +3 more
wiley   +1 more source

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies

Molecular Oncology, EarlyView.
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck, Nele De Meulenaere, Thomas Vanpoucke, Joe Ibrahim, Dieter Peeters, Suresh Krishan Yogeswaran, Wen Wen, Paul Van Schil, Jeroen M. H. Hendriks, Jo Raskin, Jan van Meerbeeck, Guy Van Camp, Ken Op de Beeck   +12 more
wiley   +1 more source

Burden and impact of pulmonary embolism in young adults hospitalized with sarcoidosis: Underreported data from nationwide analysis (2016–2020)

Lung India
Background: Studies in the past have demonstrated an association between sarcoidosis and pulmonary embolism (PE), but little is known about its impact, especially in young adults.
Aditi K. Bhanushali, Pooja Suchday, Harsh Sura, Jay Patel, Lohithasya C. Chunduru, Moulika Kari, Shrikanth Sampath, Giorgi Chilingarashvili, Rupak Desai   +8 more
doaj   +1 more source

Hospital Costs Of Extracorporeal Life Support Therapy

Critical Care Medicine, 2015
Objectives:To conduct an exploration of the hospital costs of extracorporeal life support therapy. Extracorporeal life support seems an efficient therapy for acute, potentially reversible cardiac or respiratory failure, when conventional therapy has been
A. Oude Lansink-Hartgring, B. van den Hengel, W. van der Bij, M. Erasmus, M. Mariani, M. Rienstra, V. Cernak, K. Vermeulen, W. M. van den Bergh   +8 more
semanticscholar   +1 more source